Insight Molecular Diagnostics (IMDX) Cash from Investing Activities (QoQ) (2015 - 2026)
Insight Molecular Diagnostics (IMDX) Cash from Investing Activities (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn |
| 10 | Insight Molecular Diagnostics | 4.44 Mn | -24.49 Mn | 15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 58.55% |
| Dec 31, 2025 | -40.86% |
| Sep 30, 2025 | -200.86% |
| Jun 30, 2025 | -13.68% |
| Mar 31, 2025 | -46.19% |
| Dec 31, 2024 | -141.38% |
| Sep 30, 2024 | 54.45% |
| Jun 30, 2024 | -695.83% |
| Mar 31, 2024 | -123.30% |
| Dec 31, 2023 | -51.87% |
| Sep 30, 2023 | 73.98% |
| Jun 30, 2023 | 108.97% |
| Mar 31, 2023 | -71.07% |
| Dec 31, 2022 | 6.64% |
| Sep 30, 2022 | 23.17% |
| Jun 30, 2022 | 28.38% |
| Mar 31, 2022 | -289.28% |
| Dec 31, 2021 | -1.78% |
| Sep 30, 2021 | 91.95% |
| Jun 30, 2021 | 40.84% |